Actively Recruiting

Phase 2
Phase 3
Age: 20Years +
All Genders
NCT06747130

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

Led by Phramongkutklao College of Medicine and Hospital · Updated on 2025-05-29

82

Participants Needed

1

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if drug montelukast works to treat dengue in adults. It will also learn about the safety of drug montelukast . The main questions it aims to answer are: Does drug montelukast lower the incidence of liver enzyme elevations in participants ? What medical problems do participants have when taking drug montelukast ?

CONDITIONS

Official Title

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient age >18 years
  • Dengue infection diagnosed by NS1 antigen or polymerase chain reaction
  • Admitted to the hospital
  • Written informed consent from patient or attending relative able to and willing to give informed consent
Not Eligible

You will not qualify if you...

  • Other possible cause of fever besides dengue infection
  • Pregnancy
  • Unable to take medication
  • Aminotransferase level above 150 U/l
  • Allergy to paracetamol or tramadol
  • Paracetamol needed for condition other than dengue infection
  • Critically ill patient requiring ICU or invasive ventilation
  • History of cirrhosis
  • Unable to communicate
  • Other indication for montelukast
  • History of psychiatric illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Phramongkutklao Hospital

Bangkok, Thailand, 10400

Actively Recruiting

Loading map...

Research Team

V

Vasin Vasikasin, MD PhD

CONTACT

K

Kotchaphon Waithayakul, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here